Cargando…

Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy

A common process associated with oxidative stress and severe mitochondrial impairment is the opening of the mitochondrial permeability transition pore, as described in many neurodegenerative diseases. Thus, inhibition of mitochondrial permeability transition pore opening represents a potential targe...

Descripción completa

Detalles Bibliográficos
Autores principales:	López-Erauskin, Jone, Galino, Jorge, Bianchi, Patrizia, Fourcade, Stéphane, Andreu, Antoni L., Ferrer, Isidre, Muñoz-Pinedo, Cristina, Pujol, Aurora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2012
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525057/ https://www.ncbi.nlm.nih.gov/pubmed/23250880 http://dx.doi.org/10.1093/brain/aws292

Ejemplares similares

Antioxidants Halt Axonal Degeneration in a Mouse Model of X-Adrenoleukodystrophy
por: López-Erauskin, Jone, et al.
Publicado: (2011)

Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy
por: Launay, Nathalie, et al.
Publicado: (2016)

Autophagy induction halts axonal degeneration in a mouse model of X-adrenoleukodystrophy
por: Launay, Nathalie, et al.
Publicado: (2014)

Glutathione imbalance in patients with X-linked adrenoleukodystrophy()
por: Petrillo, Sara, et al.
Publicado: (2013)

Epigenomic signature of adrenoleukodystrophy predicts compromised oligodendrocyte differentiation
por: Schlüter, Agatha, et al.
Publicado: (2018)

Oxidative stress and mitochondrial dynamics malfunction are linked in Pelizaeus‐Merzbacher disease
por: Ruiz, Montserrat, et al.
Publicado: (2017)

Aberrant regulation of the GSK‐3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy
por: Ranea‐Robles, Pablo, et al.
Publicado: (2018)

Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy
por: Schlüter, Agatha, et al.
Publicado: (2012)

Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy
por: Weinhofer, Isabelle, et al.
Publicado: (2023)

Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation
por: Engelen, Marc, et al.
Publicado: (2012)

Bezafibrate for X-Linked Adrenoleukodystrophy
por: Engelen, Marc, et al.
Publicado: (2012)

Pathophysiology of X-linked adrenoleukodystrophy()
por: Berger, J., et al.
Publicado: (2014)

Anti-oxidant MitoQ rescue of AWB chemosensory neuron impairment in a C. elegans model of X-linked Adrenoleukodystrophy
por: Guha, Sanjib, et al.
Publicado: (2021)

X-linked adrenoleukodystrophy in 8 patients
por: Meng, Zhe, et al.
Publicado: (2015)

An unusual presentation of X-linked adrenoleukodystrophy
por: Suryawanshi, Avinash, et al.
Publicado: (2015)

Newborn Screening for X-Linked Adrenoleukodystrophy
por: Moser, Ann B., et al.
Publicado: (2016)

Impaired plasticity of macrophages in X-linked adrenoleukodystrophy
por: Weinhofer, Isabelle, et al.
Publicado: (2018)

Isolated Cerebellar Involvement in X-linked Adrenoleukodystrophy
por: Mansoor, C. A.
Publicado: (2020)

X-linked adrenoleukodystrophy and primary adrenal insufficiency
por: Cappa, Marco, et al.
Publicado: (2023)

Management of X-linked adrenoleukodystrophy in Morocco: actual situation
por: Benjelloun, F. Z. Madani, et al.
Publicado: (2017)

The value of the speech audiometry in diagnosis of X-linked adrenoleukodystrophy
por: Chen, Jing-Jing, et al.
Publicado: (2016)

Disease progression in women with X-linked adrenoleukodystrophy is slow
por: Huffnagel, Irene C., et al.
Publicado: (2019)

X-LINKED ADRENOLEUKODYSTROPHY IN BRAZIL: A CASE SERIES
por: Furlan, Fernanda Luiza Schumacher, et al.
Publicado: (2019)

Vorinostat in the acute neuroinflammatory form of X‐linked adrenoleukodystrophy
por: Zierfuss, Bettina, et al.
Publicado: (2020)

Deciphering the modifiers for phenotypic variability of X-linked adrenoleukodystrophy
por: Palakuzhiyil, Shruti V, et al.
Publicado: (2020)

The Role of Oxidative Stress and Inflammation in X-Link Adrenoleukodystrophy
por: Yu, Jiayu, et al.
Publicado: (2022)

Pain Study in X-Linked Adrenoleukodystrophy in Males and Females
por: Bachiocco, Valeria, et al.
Publicado: (2021)

Antioxidant Response in Human X-Linked Adrenoleukodystrophy Fibroblasts
por: Petrillo, Sara, et al.
Publicado: (2022)

Sex‐specific newborn screening for X‐linked adrenoleukodystrophy
por: Albersen, Monique, et al.
Publicado: (2022)

X-linked adrenoleukodystrophy presenting as attention deficit hyperactivity disorder
por: Ilango, T. Siva, et al.
Publicado: (2015)

Clinical Manifest X-Linked Recessive Adrenoleukodystrophy in a Female
por: Jack, Gyda Hlin Skuladottir, et al.
Publicado: (2013)

X-linked adult-onset adrenoleukodystrophy: Psychiatric and neurological manifestations
por: Shamim, Daniah, et al.
Publicado: (2017)

Guillain Barré Syndrome in a Child With X-Linked Adrenoleukodystrophy
por: Jacob, Ron, et al.
Publicado: (2015)

Family Perspectives on Newborn Screening for X-Linked Adrenoleukodystrophy in California
por: Schwan, Katharina, et al.
Publicado: (2019)

A Tanzanian Boy with Molecularly Confirmed X-Linked Adrenoleukodystrophy
por: Dekker, M. C. J., et al.
Publicado: (2019)

Evaluation of X-Linked Adrenoleukodystrophy Newborn Screening in North Carolina
por: Lee, Stacey, et al.
Publicado: (2020)

Magnetic resonance spectroscopy as marker for neurodegeneration in X-linked adrenoleukodystrophy
por: van de Stadt, Stephanie I.W., et al.
Publicado: (2021)

Newborn Screening for X-Linked Adrenoleukodystrophy: The Initial Illinois Experience
por: Burton, Barbara K., et al.
Publicado: (2022)

Newborn Screening for X-Linked Adrenoleukodystrophy: Past, Present, and Future
por: Moser, Ann B., et al.
Publicado: (2022)

Role of MRI in X-linked adrenoleukodystrophy—A case report
por: Aryal, Sajiva, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5kb03tselefv4vliit7r8hqatr